These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24194502)

  • 21. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases.
    Kim J; Eckhart AD; Eguchi S; Koch WJ
    J Biol Chem; 2002 Aug; 277(35):32116-23. PubMed ID: 12048215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rap1 promotes multiple pancreatic islet cell functions and signals through mammalian target of rapamycin complex 1 to enhance proliferation.
    Kelly P; Bailey CL; Fueger PT; Newgard CB; Casey PJ; Kimple ME
    J Biol Chem; 2010 May; 285(21):15777-85. PubMed ID: 20339002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel insulin sensitizer modulates nutrient sensing pathways and maintains β-cell phenotype in human islets.
    Rohatgi N; Aly H; Marshall CA; McDonald WG; Kletzien RF; Colca JR; McDaniel ML
    PLoS One; 2013; 8(5):e62012. PubMed ID: 23650507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
    Kang S; Chemaly ER; Hajjar RJ; Lebeche D
    J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen.
    Zhang H; Zhang J; Pope CF; Crawford LA; Vasavada RC; Jagasia SM; Gannon M
    Diabetes; 2010 Jan; 59(1):143-52. PubMed ID: 19833884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FoxM1 is up-regulated by obesity and stimulates beta-cell proliferation.
    Davis DB; Lavine JA; Suhonen JI; Krautkramer KA; Rabaglia ME; Sperger JM; Fernandez LA; Yandell BS; Keller MP; Wang IM; Schadt EE; Attie AD
    Mol Endocrinol; 2010 Sep; 24(9):1822-34. PubMed ID: 20660304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways.
    MacDonald PE; Wang X; Xia F; El-kholy W; Targonsky ED; Tsushima RG; Wheeler MB
    J Biol Chem; 2003 Dec; 278(52):52446-53. PubMed ID: 14565957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGFR signaling promotes β-cell proliferation and survivin expression during pregnancy.
    Hakonen E; Ustinov J; Palgi J; Miettinen PJ; Otonkoski T
    PLoS One; 2014; 9(4):e93651. PubMed ID: 24695557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
    Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG
    J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1.
    Ackermann Misfeldt A; Costa RH; Gannon M
    Diabetes; 2008 Nov; 57(11):3069-77. PubMed ID: 18728229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling mechanisms of heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells.
    Reynolds CM; Eguchi S; Frank GD; Motley ED
    Hypertension; 2002 Feb; 39(2 Pt 2):525-9. PubMed ID: 11882602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose Induces Mouse β-Cell Proliferation via IRS2, MTOR, and Cyclin D2 but Not the Insulin Receptor.
    Stamateris RE; Sharma RB; Kong Y; Ebrahimpour P; Panday D; Ranganath P; Zou B; Levitt H; Parambil NA; O'Donnell CP; García-Ocaña A; Alonso LC
    Diabetes; 2016 Apr; 65(4):981-95. PubMed ID: 26740601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human β-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map.
    Bernal-Mizrachi E; Kulkarni RN; Scott DK; Mauvais-Jarvis F; Stewart AF; Garcia-Ocaña A
    Diabetes; 2014 Mar; 63(3):819-31. PubMed ID: 24556859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells.
    Yu W; Cui X; Wan Z; Yu Y; Liu X; Jin L
    J Cell Biochem; 2018 Nov; 119(11):9090-9098. PubMed ID: 29953672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway.
    Cao C; Huang X; Han Y; Wan Y; Birnbaumer L; Feng GS; Marshall J; Jiang M; Chu WM
    Sci Signal; 2009 Apr; 2(68):ra17. PubMed ID: 19401591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells.
    Wang Q; Cai Y; Van de Casteele M; Pipeleers D; Ling Z
    J Endocrinol; 2011 Feb; 208(2):161-9. PubMed ID: 21084384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal signals regulate obesity induced β-cell proliferation by FoxM1 dependent mechanism.
    Yamamoto J; Imai J; Izumi T; Takahashi H; Kawana Y; Takahashi K; Kodama S; Kaneko K; Gao J; Uno K; Sawada S; Asano T; Kalinichenko VV; Susaki EA; Kanzaki M; Ueda HR; Ishigaki Y; Yamada T; Katagiri H
    Nat Commun; 2017 Dec; 8(1):1930. PubMed ID: 29208957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High doses of dexamethasone induce increased beta-cell proliferation in pancreatic rat islets.
    Rafacho A; Cestari TM; Taboga SR; Boschero AC; Bosqueiro JR
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E681-9. PubMed ID: 19158320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.
    Fraenkel M; Ketzinel-Gilad M; Ariav Y; Pappo O; Karaca M; Castel J; Berthault MF; Magnan C; Cerasi E; Kaiser N; Leibowitz G
    Diabetes; 2008 Apr; 57(4):945-57. PubMed ID: 18174523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.